Prelude Capital Management, LLC Novavax Inc Put Options Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $564,813 - $1.16 Million	-8,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $71,120 - $108,232	400 Added 5.19%	8,100 $1.68 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $350,238 - $991,783	3,100 Added 67.39%	7,700 $1.4 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $362,204 - $641,700	4,600 New	4,600 $513,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.